Wagner Paul A.'s Form 4 filing
Forte Biosciences, Inc. (FBRX) · filed Dec 8, 2023
- Accession no.
- 0001209191-23-057989
- Filed
- Dec 8, 2023
- Trade date
- Dec 7-8, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $30.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wagner Paul A.CIK 0001612842 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2023 | Common Stock | PPurchaseAcquired | +36,203 | $0.58 | +$20,997.74 | 1,747,940 | Direct | |
| Dec 8, 2023 | Common Stock | PPurchaseAcquired | +15,000 | $0.62 | +$9,300 | 1,762,940 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.